Table II.
Associations between clinicopathological data of patients with nasopharyngeal carcinoma and SERPINC1 expression.
| SERPINC1 expression | ||||
|---|---|---|---|---|
| Clinicopathological factor | N | Low | High | P-value |
| Gender | 0.756 | |||
| Female | 23 | 11 | 12 | |
| Male | 18 | 10 | 8 | |
| Age | 0.756 | |||
| <50 | 18 | 10 | 8 | |
| >50 | 23 | 11 | 12 | |
| TNM stage | 0.536 | |||
| I–II | 19 | 11 | 8 | |
| III–IV | 22 | 10 | 12 | |
| Metastasis | 0.015a | |||
| Yes | 11 | 2 | 9 | |
| No | 30 | 19 | 11 | |
P<0.05. SERPINC1, serpin peptidase inhibitor clade C member 1; TNM, tumor, node and metastasis.